جست‌وجوی استاد و پژوهشگر

Julia Teviniمشاهده پروفایل

پژوهشگر

• Biochemistry
• Molecular Biology
• Metabolomics
• +۴ مورد دیگر

Dr. Julia Tevini is a research scientist at the Salk Institute specializing in receptor biochemistry and tumor metabolism. She holds both MSc and PhD degrees and maintains an active research program with 28 publications spanning from 2019 to 2025. Her educational background includes a Master of Science (MSc) and Doctor of Philosophy (PhD), though specific institutions and dates are not provided in the available information. Dr. Tevini's research spans multiple interconnected fields in biochemical and molecular analysis. Her primary interests include: Biochemistry and Molecular Biology - with focus on receptor signaling mechanisms Metabolomics - particularly in relation to disease states Tumor Metabolism - investigating metabolic alterations in cancer Lipidomics - studying lipid profiles in various conditions Epigenetics - examining DNA methylation patterns as biomarkers Neuroscience - particularly related to Alzheimer's disease mechanisms Her publication record demonstrates significant interdisciplinary work, bridging biochemistry, oncology, neuroscience, and analytical techniques. Key research themes include metabolite signatures in various diseases, epigenetic biomarkers for cancer risk assessment, and molecular mechanisms in neurodegenerative conditions. She frequently employs advanced analytical techniques such as tandem mass spectrometry and high-performance liquid chromatography in her research. Dr. Tevini has been involved in significant research projects, including a completed project on 'Non-alcoholic fatty liver disease and hepatocellular cancer: Regulation of apoptosis by the lipid droplet proteome and lipidome' (2020-2021). Her collaborative approach is evident in her multi-author publications across various journals including Neural Regeneration Research, JCI Insight, Communications Medicine, and International Journal of Molecular Sciences.

Wilfried Ellmeierمشاهده پروفایل

استاد

• Immunology
• T Cell Biology
• Epigenetic Regulation
• +۸ مورد دیگر

Wilfried Ellmeier is a Professor of Immunobiology and Head of the Institute of Immunology at the Medical University of Vienna. He is a Corresponding Member of the Austrian Academy of Sciences (Division of Mathematics and Natural Sciences) since 2012, with a focus on epigenetic and transcriptional mechanisms governing T cell development, function, and T cell-mediated immunity. His work bridges immunology, molecular biology, and translational medicine, particularly in autoimmune diseases and lymphomagenesis. Education: Biochemistry (Diploma, University of Vienna, 1990), Molecular Pathology (PhD, University of Vienna/IMP, 1994), Postdoctoral studies (Skirball Institute/NYU Medical Center, 1995–1999) His research centers on histone deacetylases (HDACs) as key regulators of T cell immunity in health and disease, including autoimmune conditions like rheumatoid arthritis and intestinal inflammation. His lab employs multi-color flow cytometry, mouse genetics, next-gen sequencing, and immunometabolic approaches to dissect these mechanisms. Recent publications highlight HDAC1 as a therapeutic target in arthritis, immunomodulatory effects of bile acids like 24-Nor-ursodeoxycholic acid, epigenetic control of Treg/Th17 differentiation, and metabolic reprogramming of CAR T cells. These reflect his contributions to immunometabolism and precision therapy. Scientific Awards: START-Preis (FWF), Novartis-Preis für Biologie, APART Stipendium, Förderungspreis der Stadt Wien, Habilitation Prize from VFWF Ellmeier leads the FWF-funded SFB-F70 ‘HIT’ program (since 2019) and chairs the Austrian Society for Allergology and Immunology (ÖGAI, 2023–2024). His lab homepage at ellmeierlab.org details collaborative projects in T cell biology and European biomedical policy.

Elena Santiagoمشاهده پروفایل

استاد

• Evolutionary and population genetics
• Molecular epidemiology and phylogenomics
• Genomics
• +۶ مورد دیگر

Elena Santiago is a Professor at the Institute of Integrative Systems Biology (I2SysBio) under the Spanish National Research Council (CSIC) since 2018. She also holds external professor status at the Santa Fe Institute (USA) and has previously served as an Adjunct Professor at the Chinese Academy of Agricultural Sciences (CAAS). Her research focuses on RNA virus evolution, virus-host interactions, and mathematical modeling of viral population dynamics. Biochemistry Degree PhD in Evolutionary Molecular Genetics of RNA viruses from the University of Valencia Postdoctoral fellowship in microbial experimental evolution at Michigan State University Her work integrates experimental evolution, molecular biology, omics approaches, and computational modeling to study how RNA viruses adapt to hosts and manipulate cellular resources. Recent studies highlight viral transitions from parasitism to mutualism under environmental stress, transcriptomic/epigenomic reprogramming in plant defenses, and the role of transmission modes in viral population structure. Santiago's research has led to over 270 publications with 18,907 citations (H=69) and >300 conference contributions. She has secured 30 grants from prestigious institutions like EMBO, NSF, and EU FP7, and her work includes >80 invited seminars globally. Elected EMBO Young Investigator (2005) Young Virologist Award (2006) Elected EMBO Member (2011) Elected member of American Academy of Arts and Sciences (2020) She has supervised 23 PhD theses and 20 postdocs, and her lab collaborates internationally. Research contracts with industry total over €16 million, reflecting the translational impact of her work in systems virology.

Balasubramanian Shankarمشاهده پروفایل

استاد

• Molecular Biophysics
• Chemical Biology of Nucleic Acids
• Alternative DNA/RNA Structures
• +۳ مورد دیگر

Shankar Balasubramanian is a Professor at the University of Cambridge, holding a joint faculty appointment in the Department of Chemistry and the School of Clinical Medicine. He is renowned for pioneering advancements in nucleic acid research, particularly in DNA sequencing technologies and the study of alternative DNA/RNA structures. His work bridges molecular biophysics and chemical biology, focusing on understanding how DNA structure and modifications influence gene regulation and cellular processes, with implications for cancer and degenerative diseases. His research employs interdisciplinary approaches, from biophysical methods to genomic techniques, targeting G-quadruplex structures and epigenetic modifications. He leads the Balasubramanian Lab at the Cancer Research UK Cambridge Institute, developing tools like next-generation sequencing and methods to analyze DNA modifications. Key contributions include the reversible terminator sequencing chemistry, foundational for modern genomic studies. Awards: Breakthrough Prize in Life Sciences, Royal Medal, Millennium Technology Prize, and knighthood for contributions to sequencing. Lab Focus: G-quadruplex dynamics, epigenetic regulation, and applications to oncology. Collaborations: Joint appointments and cross-disciplinary projects spanning chemistry, medicine, and biotechnology. His research has driven technological innovations, including DNA sequencing methodologies and tools for studying secondary structures, profoundly impacting biomedical research and clinical applications.

Maria A. Blascoمشاهده پروفایل

پژوهشگر

• Telomeres and Telomerase
• Cancer
• Aging
• +۶ مورد دیگر

Maria A. Blasco is a leading researcher at the Spanish National Cancer Research Centre (CNIO), where she has served as Head of the Telomeres and Telomerase Group since 2003. She previously directed the Molecular Oncology Program (2003-2011) and served as Vice-Director of Basic Research (2005-2011) at CNIO, establishing herself as a pivotal figure in Spanish cancer research. Her academic foundation includes a BSc (1989) and PhD (1993) in Biochemistry and Molecular Biology from Autónoma University, Madrid, followed by postdoctoral training at Cold Spring Harbor Laboratory under Nobel laureate Dr. Carol W. Greider (1993-1996), where she specialized in telomere biology. Dr. Blasco's research program centers on telomeres and telomerase, investigating their mechanistic roles in cancer initiation and aging processes. Her work bridges epigenetics, stem cell reprogramming (including induced pluripotent stem cells), and nuclear dynamics to explore longevity determinants and health span extension. This integrative approach has positioned her at the forefront of understanding how telomere dysfunction drives oncogenesis and age-related pathologies. Her transformative contributions have earned international recognition through numerous prestigious awards: Körber European Science Award (2008) Rey Jaime I Prize for Basic Research (2007) Member of Academia Europaea (2006) Josef Steiner Cancer Research Award (2003) Universalia Research Award (2003) European Life Sciences Organization Early Career Award (2002) SEBBM Beckman/Coulter Award (2001) Swiss Bridge Award for Cancer Research (2000) Fellow of the Royal Academy of Pharmacy of Spain (2013) Santiago Grisolía Chair in Biomedicine (2012) While Dr. Blasco has undoubtedly mentored emerging scientists through her leadership roles, specific student names are not documented in the provided materials. Her administrative positions as Program Director and Vice-Director indicate substantial grant management expertise, though individual funding details remain unspecified. As head of the Telomeres and Telomerase Group, she directs a multidisciplinary team employing advanced molecular and cellular techniques to dissect telomere maintenance mechanisms. Her laboratory's work continues to illuminate critical connections between telomere biology, genomic instability, and therapeutic interventions for cancer and aging-related diseases.

Eulàlia de Nadalمشاهده پروفایل

استاد

• Cellular Signaling
• Stress Responses
• Transcription Regulation
• +۳ مورد دیگر

Eulàlia de Nadal is the Rector of the University Pompeu Fabra (UPF, Barcelona) since 2023 and a Full Professor in the Department of Medicine and Life Sciences (MELIS). She has held leadership roles including Vice-rector for Knowledge Transfer (2021–2023) and Vice-director of the Department of Experimental and Health Sciences (2015–2019). She earned a Veterinary Medicine degree (UAB, 1995) and a Ph.D. in Biochemistry & Molecular Biology (UAB, 2000). Her research focuses on cellular signaling, stress responses, and transcription regulation, with a particular emphasis on genomic stability and cancer biology. Key research contributions include studies on histone modifications under stress, genomic integrity mechanisms, and RB protein regulation in cancer. She leads the Cell Signaling group at UPF and is an Affiliated Group Leader at IRB Barcelona. Her work has been supported by 6 Spanish Government grants and multiple international collaborations. She has published 54 original articles (43 in the last decade) with an h-index of 34. Awards : Two ICREA Acadèmia Awards (2012–2016 & 2021–2025), Special Doctoral Thesis Award (2001). Advising : Co-supervised 14 doctoral theses and currently supervises 5 pre-doctoral students. Grants : Principal investigator of 6 national projects (2005–2023); collaborations with EU, Catalan Government, and private entities. Her lab integrates epigenetic, genomic, and proteomic approaches to study stress signaling pathways and their translational impact on health and disease.

Miodrag Stojkovicمشاهده پروفایل

استاد

• Embryology
• Stem Cell Biology
• Differentiation
• +۲ مورد دیگر

Miodrag Stojkovic is a Serbian professor of human genetics at the Medical Faculty, University of Kragujevac, with a distinguished career spanning institutions in Germany, the UK, Spain, and Serbia. He is also President of the Board of the Institute of Molecular Genetics and Genetic Engineering (IMGGI) in Belgrade and holds visiting professorships at a Medical School and Military Medical Academy in Serbia. Education: Doctorate from Ludwig-Maximilians University (1996) Habil degree from Ludwig-Maximilians University (2002) His research focuses on embryology, stem cell biology, and regenerative medicine. He has pioneered work in human embryonic stem cells, nuclear transfer, and epigenetics, including breakthroughs in hematopoietic differentiation, spinal cord injury repair, and hypoxia-induced endothelial differentiation. His work bridges fundamental developmental biology with clinical applications in fertility and regenerative therapies. Stojkovic's publications highlight trends in human embryonic stem cell applications, neuroregeneration, vascular biology, and epigenetic profiling of IVF-derived embryos. His studies often integrate interdisciplinary approaches, combining molecular biology, cell culture optimization, and in vivo models. Scientific Honors: Member of National Academy of Veterinary Medicine (2010) Honorary Member of National Academy of Medical Sciences (2010) He has secured major grants totaling €14.17 million, including €6 million from Spanish CONSOLIDAR, €5.17 million from the Serbian Ministry of Science and Technology, and €2.999 million from the EU FP7 HEALTH-2007 Collaborative Project. Stojkovic served as Editor of STEM CELLS (2005–2011) and founded Spebo Medical, a fertility clinic in Leskovac, Serbia.

Azim Suraniمشاهده پروفایل

استاد

• Developmental biology
• Epigenetics

Azim Surani is a Professor at the University of Cambridge, UK, specializing in developmental biology and epigenetics. Elected as an Ordinary Member of the Academy of Europe in 1994 (Section: Cell & Developmental Biology), his research has profoundly impacted understanding of epigenetic regulation in early embryonic development. His scholarly work centers on genomic imprinting, epigenetic reprogramming, and establishment of totipotency in mammalian embryos. Professor Surani's investigations elucidate critical pathways for parental genome resetting during gametogenesis and fertilization, shaping developmental potential through molecular and cellular mechanisms. Professor Surani's exceptional contributions have been recognized with prestigious awards: Fellow of the Royal Society (1990) Gabor Medal of the Royal Society (2001) Rosenstiel Award (2007) Royal Medal of the Royal Society (2010)

Maria-Elena Torres-Padillaمشاهده پروفایل

استاد

• Epigenetics
• Stem Cell Biology
• Early Mammalian Development
• +۶ مورد دیگر

Maria-Elena Torres-Padilla is a Director at the Helmholtz Centre Munich and Full Professor (W3) for Stem Cell Biology at the Ludwig-Maximilians University, Munich . She leads the Institute of Epigenetics & Stem Cells and the Stem Cell Centre , with affiliations to the Helmholtz Pioneer Campus and IGBMC, Strasbourg . Education : Habilitation in Molecular & Cellular Biology (2008, Université Louis Pasteur); PhD in Molecular & Cellular Biology (1998–2002, Université Paris V/Institut Pasteur); University degree in Biology (1994–1998, National University of Mexico). Research Interests focus on epigenetics , chromatin dynamics , stem cell biology , and early mammalian development . Her work explores nuclear organization, totipotency, and reprogramming mechanisms during embryogenesis, with a strong emphasis on histone variants, heterochromatin regulation, and 3D genome architecture. Her publications span high-impact journals like Nature , Nature Cell Biology , and Nature Genetics , with a focus on epigenetic reprogramming, chromatin accessibility, and cell fate decisions. She has authored 84 publications, including 62 as first or corresponding author. Scientific Awards & Leadership Roles : 2023: Member, German National Academy of Sciences (Leopoldina) and Latin American Academy of Sciences (ACAL) 2021–2023: Editorial Board Member, Science and Cell Stem Cell 2020: NIH 4D Nucleome Project Principal Investigator Award 2019–2021: Founding member and Work Package Leader, LifeTime Initiative 2018–2023: Steering Board Member, Single Cell Omics Germany She actively participates in interdisciplinary networks , including EpiGeneSys , Helmholtz Think Tank , and NIH 4D Nucleome advisory roles, while organizing major conferences like the Gordon Research Conference on Epigenetics and FASEB Methylation Meetings .

Stefan Kubicekمشاهده پروفایل

پژوهشگر

• Chemical Epigenetics
• Chromatin Biology
• Cancer Biology
• +۵ مورد دیگر

Stefan Kubicek is a Principal Investigator and Head of the Molecular Discovery Platform at CeMM (Center for Molecular Medicine of the Austrian Academy of Sciences). His research bridges Chemical Biology and Epigenetics , focusing on small molecules that alter cellular identity through chromatin pathways and nuclear metabolism. Previously, he led the Christian Doppler Laboratory for Chemical Epigenetics and Antiinfectives, a public-private partnership with Boehringer Ingelheim and Haplogen. MSc in Synthetic Organic Chemistry (Vienna University of Technology) PhD in Molecular Biology (Thomas Jenuwein Lab, IMP Vienna) Postdoc in Chemical Biology (Stuart Schreiber, Broad Institute) His work explores ATP-dependent chromatin remodeling in cancer and diabetes, developing chemical tools against epigenetic modifiers. Recent publications highlight nuclear metabolic targets , protein phase separation , and pancreatic cell transdifferentiation . Collaborations with pharmaceutical companies have yielded high-impact studies, including Nature Genetics (2019) on synthetic lethal cancer targets. Research Funding includes: ERC Proof of Concept Grant (ONCO-SPLICE, 2024-2026) FWF Stand-Alone Program (2024-2027) WWTF Life Sciences Grant (2022-2025) Breakthrough T1D Award (2024-2025) Lab members include Predoctoral Fellows (Sandra Goll, Andreas Reicher, Jamie Reilly, Jiri Reinis, Jonathan Shklarek), Postdoctoral Fellows (Tuan-Anh Nguyen), and technicians (Maria Ciobanu, Diana Daum). His team deploys high-throughput screening , genetic code expansion , and stochastic protein tagging to uncover nuclear metabolic-epigenetic connections.